Loading…
Prevalence of Cognitive and Functional Impairment in a Community Sample from São Paulo, Brazil
Aims: To present the prevalence of cognitive and functional impairment (CFI) in community-dwelling elderly subjects from the city of São Paulo. Methods: The population was aged 60 years and older (n = 1,563; 68.7% women and 31.3% men) and lived in different socioeconomic areas. The following instrum...
Saved in:
Published in: | Dementia and geriatric cognitive disorders 2008-01, Vol.25 (2), p.135-143 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c392t-5ca1ea3c82d6b15fce1e368e6ba96b60605655d6b357531d6d06b1b47fd299003 |
---|---|
cites | cdi_FETCH-LOGICAL-c392t-5ca1ea3c82d6b15fce1e368e6ba96b60605655d6b357531d6d06b1b47fd299003 |
container_end_page | 143 |
container_issue | 2 |
container_start_page | 135 |
container_title | Dementia and geriatric cognitive disorders |
container_volume | 25 |
creator | Hototian, Sergio R. Lopes, Marcos A. Azevedo, Dionisio Tatsch, Mariana Bazzarella, Mario C. Bustamante, Sonia E.Z. Litvoc, Julio Bottino, Cássio M.C. |
description | Aims: To present the prevalence of cognitive and functional impairment (CFI) in community-dwelling elderly subjects from the city of São Paulo. Methods: The population was aged 60 years and older (n = 1,563; 68.7% women and 31.3% men) and lived in different socioeconomic areas. The following instruments were administered to the elderly: the Mini Mental State Examination and the Fuld Object Memory Evaluation. The Informant Questionnaire on Cognitive Decline in the Elderly and the Bayer-Activities of Daily Living scale were administered to an informant. Results: The prevalence of CFI (n = 250) was 16% (95% confidence interval, CI: 14.2–17.8%) or 15.8% (95% CI: 13.8–17.8%). In regression models, the increase in the odds ratio (OR) of CFI was associated with age, for elderly individuals aged 75 years or older, illiterates or with 1–4 years of schooling, and with a history of stroke and diabetes mellitus. On the other hand, for subjects with a tumor history, the OR of CFI was significantly reduced. Conclusion: CFI was high and increased at older ages and in subjects with low education. Potentially changeable factors were identified (stroke and diabetes), and the possible ‘protective effect’ of tumor/cancer against CFI should be further investigated by longitudinal studies. |
doi_str_mv | 10.1159/000112554 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_232508447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20694153</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-5ca1ea3c82d6b15fce1e368e6ba96b60605655d6b357531d6d06b1b47fd299003</originalsourceid><addsrcrecordid>eNqF0dtqFTEUBuAgij3ohfciQWhBcHTlOMmlbuwBChaq10MmkympmWQ3mSnU1_FRfDHT7k0L3vQqgXz8a5EfoTcEPhEi9GcAIIQKwZ-hXcIpabSi_Pn9HRoFoHbQXilXlbVC6pdohyjQLeFkF3Xn2d2Y4KJ1OI14lS6jn_2NwyYO-GiJdvYpmoBPp7XxeXJxxj5iU-E0LZXe4gszrYPDY04Tvvj7J-Fzs4T0EX_N5rcPr9CL0YTiXm_PffTz6NuP1Ulz9v34dPXlrLFM07kR1hBnmFV0kD0Ro3XEMamc7I2WvQQJQgpR35hoBSODHKC6nrfjQLUGYPvocJO7zul6cWXuJl-sC8FEl5bStUC5YoI9CSlIzck9fP8fvEpLrn9RDaMCFOdtRR82yOZUSnZjt85-Mvm2I9DdddM9dFPtu23g0k9ueJTbMio42AJTrAljNtH68uAoAFVK3W32duN-mXzp8mPQZs4_TF2dhw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>232508447</pqid></control><display><type>article</type><title>Prevalence of Cognitive and Functional Impairment in a Community Sample from São Paulo, Brazil</title><source>Social Science Premium Collection</source><creator>Hototian, Sergio R. ; Lopes, Marcos A. ; Azevedo, Dionisio ; Tatsch, Mariana ; Bazzarella, Mario C. ; Bustamante, Sonia E.Z. ; Litvoc, Julio ; Bottino, Cássio M.C.</creator><creatorcontrib>Hototian, Sergio R. ; Lopes, Marcos A. ; Azevedo, Dionisio ; Tatsch, Mariana ; Bazzarella, Mario C. ; Bustamante, Sonia E.Z. ; Litvoc, Julio ; Bottino, Cássio M.C.</creatorcontrib><description>Aims: To present the prevalence of cognitive and functional impairment (CFI) in community-dwelling elderly subjects from the city of São Paulo. Methods: The population was aged 60 years and older (n = 1,563; 68.7% women and 31.3% men) and lived in different socioeconomic areas. The following instruments were administered to the elderly: the Mini Mental State Examination and the Fuld Object Memory Evaluation. The Informant Questionnaire on Cognitive Decline in the Elderly and the Bayer-Activities of Daily Living scale were administered to an informant. Results: The prevalence of CFI (n = 250) was 16% (95% confidence interval, CI: 14.2–17.8%) or 15.8% (95% CI: 13.8–17.8%). In regression models, the increase in the odds ratio (OR) of CFI was associated with age, for elderly individuals aged 75 years or older, illiterates or with 1–4 years of schooling, and with a history of stroke and diabetes mellitus. On the other hand, for subjects with a tumor history, the OR of CFI was significantly reduced. Conclusion: CFI was high and increased at older ages and in subjects with low education. Potentially changeable factors were identified (stroke and diabetes), and the possible ‘protective effect’ of tumor/cancer against CFI should be further investigated by longitudinal studies.</description><identifier>ISSN: 1420-8008</identifier><identifier>EISSN: 1421-9824</identifier><identifier>DOI: 10.1159/000112554</identifier><identifier>PMID: 18097141</identifier><identifier>CODEN: DGCDFX</identifier><language>eng</language><publisher>Basel, Switzerland: Karger</publisher><subject>Aged ; Aged, 80 and over ; Biological and medical sciences ; Brazil - epidemiology ; Catchment Area (Health) ; Cognition Disorders - diagnosis ; Cognition Disorders - epidemiology ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Neurology ; Neuropharmacology ; Neuropsychological Tests ; Original Research Article ; Pharmacology. Drug treatments ; Prevalence ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychomotor Disorders - diagnosis ; Psychomotor Disorders - epidemiology ; Psychopharmacology ; Risk Factors ; Severity of Illness Index ; Socioeconomic Factors ; Surveys and Questionnaires</subject><ispartof>Dementia and geriatric cognitive disorders, 2008-01, Vol.25 (2), p.135-143</ispartof><rights>2007 S. Karger AG, Basel</rights><rights>2008 INIST-CNRS</rights><rights>Copyright (c) 2007 S. Karger AG, Basel.</rights><rights>Copyright (c) 2008 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-5ca1ea3c82d6b15fce1e368e6ba96b60605655d6b357531d6d06b1b47fd299003</citedby><cites>FETCH-LOGICAL-c392t-5ca1ea3c82d6b15fce1e368e6ba96b60605655d6b357531d6d06b1b47fd299003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/232508447/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/232508447?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,21394,27924,27925,33611,33612,43733,74221</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20028883$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18097141$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hototian, Sergio R.</creatorcontrib><creatorcontrib>Lopes, Marcos A.</creatorcontrib><creatorcontrib>Azevedo, Dionisio</creatorcontrib><creatorcontrib>Tatsch, Mariana</creatorcontrib><creatorcontrib>Bazzarella, Mario C.</creatorcontrib><creatorcontrib>Bustamante, Sonia E.Z.</creatorcontrib><creatorcontrib>Litvoc, Julio</creatorcontrib><creatorcontrib>Bottino, Cássio M.C.</creatorcontrib><title>Prevalence of Cognitive and Functional Impairment in a Community Sample from São Paulo, Brazil</title><title>Dementia and geriatric cognitive disorders</title><addtitle>Dement Geriatr Cogn Disord</addtitle><description>Aims: To present the prevalence of cognitive and functional impairment (CFI) in community-dwelling elderly subjects from the city of São Paulo. Methods: The population was aged 60 years and older (n = 1,563; 68.7% women and 31.3% men) and lived in different socioeconomic areas. The following instruments were administered to the elderly: the Mini Mental State Examination and the Fuld Object Memory Evaluation. The Informant Questionnaire on Cognitive Decline in the Elderly and the Bayer-Activities of Daily Living scale were administered to an informant. Results: The prevalence of CFI (n = 250) was 16% (95% confidence interval, CI: 14.2–17.8%) or 15.8% (95% CI: 13.8–17.8%). In regression models, the increase in the odds ratio (OR) of CFI was associated with age, for elderly individuals aged 75 years or older, illiterates or with 1–4 years of schooling, and with a history of stroke and diabetes mellitus. On the other hand, for subjects with a tumor history, the OR of CFI was significantly reduced. Conclusion: CFI was high and increased at older ages and in subjects with low education. Potentially changeable factors were identified (stroke and diabetes), and the possible ‘protective effect’ of tumor/cancer against CFI should be further investigated by longitudinal studies.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Brazil - epidemiology</subject><subject>Catchment Area (Health)</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - epidemiology</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Neuropsychological Tests</subject><subject>Original Research Article</subject><subject>Pharmacology. Drug treatments</subject><subject>Prevalence</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychomotor Disorders - diagnosis</subject><subject>Psychomotor Disorders - epidemiology</subject><subject>Psychopharmacology</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Socioeconomic Factors</subject><subject>Surveys and Questionnaires</subject><issn>1420-8008</issn><issn>1421-9824</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>ALSLI</sourceid><sourceid>M2R</sourceid><recordid>eNqF0dtqFTEUBuAgij3ohfciQWhBcHTlOMmlbuwBChaq10MmkympmWQ3mSnU1_FRfDHT7k0L3vQqgXz8a5EfoTcEPhEi9GcAIIQKwZ-hXcIpabSi_Pn9HRoFoHbQXilXlbVC6pdohyjQLeFkF3Xn2d2Y4KJ1OI14lS6jn_2NwyYO-GiJdvYpmoBPp7XxeXJxxj5iU-E0LZXe4gszrYPDY04Tvvj7J-Fzs4T0EX_N5rcPr9CL0YTiXm_PffTz6NuP1Ulz9v34dPXlrLFM07kR1hBnmFV0kD0Ro3XEMamc7I2WvQQJQgpR35hoBSODHKC6nrfjQLUGYPvocJO7zul6cWXuJl-sC8FEl5bStUC5YoI9CSlIzck9fP8fvEpLrn9RDaMCFOdtRR82yOZUSnZjt85-Mvm2I9DdddM9dFPtu23g0k9ueJTbMio42AJTrAljNtH68uAoAFVK3W32duN-mXzp8mPQZs4_TF2dhw</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Hototian, Sergio R.</creator><creator>Lopes, Marcos A.</creator><creator>Azevedo, Dionisio</creator><creator>Tatsch, Mariana</creator><creator>Bazzarella, Mario C.</creator><creator>Bustamante, Sonia E.Z.</creator><creator>Litvoc, Julio</creator><creator>Bottino, Cássio M.C.</creator><general>Karger</general><general>S. Karger AG</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>88J</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>M2R</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20080101</creationdate><title>Prevalence of Cognitive and Functional Impairment in a Community Sample from São Paulo, Brazil</title><author>Hototian, Sergio R. ; Lopes, Marcos A. ; Azevedo, Dionisio ; Tatsch, Mariana ; Bazzarella, Mario C. ; Bustamante, Sonia E.Z. ; Litvoc, Julio ; Bottino, Cássio M.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-5ca1ea3c82d6b15fce1e368e6ba96b60605655d6b357531d6d06b1b47fd299003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Brazil - epidemiology</topic><topic>Catchment Area (Health)</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - epidemiology</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Neuropsychological Tests</topic><topic>Original Research Article</topic><topic>Pharmacology. Drug treatments</topic><topic>Prevalence</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychomotor Disorders - diagnosis</topic><topic>Psychomotor Disorders - epidemiology</topic><topic>Psychopharmacology</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Socioeconomic Factors</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hototian, Sergio R.</creatorcontrib><creatorcontrib>Lopes, Marcos A.</creatorcontrib><creatorcontrib>Azevedo, Dionisio</creatorcontrib><creatorcontrib>Tatsch, Mariana</creatorcontrib><creatorcontrib>Bazzarella, Mario C.</creatorcontrib><creatorcontrib>Bustamante, Sonia E.Z.</creatorcontrib><creatorcontrib>Litvoc, Julio</creatorcontrib><creatorcontrib>Bottino, Cássio M.C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection【Remote access available】</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest Science Journals</collection><collection>Social Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Dementia and geriatric cognitive disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hototian, Sergio R.</au><au>Lopes, Marcos A.</au><au>Azevedo, Dionisio</au><au>Tatsch, Mariana</au><au>Bazzarella, Mario C.</au><au>Bustamante, Sonia E.Z.</au><au>Litvoc, Julio</au><au>Bottino, Cássio M.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Cognitive and Functional Impairment in a Community Sample from São Paulo, Brazil</atitle><jtitle>Dementia and geriatric cognitive disorders</jtitle><addtitle>Dement Geriatr Cogn Disord</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>25</volume><issue>2</issue><spage>135</spage><epage>143</epage><pages>135-143</pages><issn>1420-8008</issn><eissn>1421-9824</eissn><coden>DGCDFX</coden><abstract>Aims: To present the prevalence of cognitive and functional impairment (CFI) in community-dwelling elderly subjects from the city of São Paulo. Methods: The population was aged 60 years and older (n = 1,563; 68.7% women and 31.3% men) and lived in different socioeconomic areas. The following instruments were administered to the elderly: the Mini Mental State Examination and the Fuld Object Memory Evaluation. The Informant Questionnaire on Cognitive Decline in the Elderly and the Bayer-Activities of Daily Living scale were administered to an informant. Results: The prevalence of CFI (n = 250) was 16% (95% confidence interval, CI: 14.2–17.8%) or 15.8% (95% CI: 13.8–17.8%). In regression models, the increase in the odds ratio (OR) of CFI was associated with age, for elderly individuals aged 75 years or older, illiterates or with 1–4 years of schooling, and with a history of stroke and diabetes mellitus. On the other hand, for subjects with a tumor history, the OR of CFI was significantly reduced. Conclusion: CFI was high and increased at older ages and in subjects with low education. Potentially changeable factors were identified (stroke and diabetes), and the possible ‘protective effect’ of tumor/cancer against CFI should be further investigated by longitudinal studies.</abstract><cop>Basel, Switzerland</cop><pub>Karger</pub><pmid>18097141</pmid><doi>10.1159/000112554</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1420-8008 |
ispartof | Dementia and geriatric cognitive disorders, 2008-01, Vol.25 (2), p.135-143 |
issn | 1420-8008 1421-9824 |
language | eng |
recordid | cdi_proquest_journals_232508447 |
source | Social Science Premium Collection |
subjects | Aged Aged, 80 and over Biological and medical sciences Brazil - epidemiology Catchment Area (Health) Cognition Disorders - diagnosis Cognition Disorders - epidemiology Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Female Humans Male Medical sciences Middle Aged Neurology Neuropharmacology Neuropsychological Tests Original Research Article Pharmacology. Drug treatments Prevalence Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychomotor Disorders - diagnosis Psychomotor Disorders - epidemiology Psychopharmacology Risk Factors Severity of Illness Index Socioeconomic Factors Surveys and Questionnaires |
title | Prevalence of Cognitive and Functional Impairment in a Community Sample from São Paulo, Brazil |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T01%3A04%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Cognitive%20and%20Functional%20Impairment%20in%20a%20Community%20Sample%20from%20S%C3%A3o%20Paulo,%20Brazil&rft.jtitle=Dementia%20and%20geriatric%20cognitive%20disorders&rft.au=Hototian,%20Sergio%20R.&rft.date=2008-01-01&rft.volume=25&rft.issue=2&rft.spage=135&rft.epage=143&rft.pages=135-143&rft.issn=1420-8008&rft.eissn=1421-9824&rft.coden=DGCDFX&rft_id=info:doi/10.1159/000112554&rft_dat=%3Cproquest_cross%3E20694153%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-5ca1ea3c82d6b15fce1e368e6ba96b60605655d6b357531d6d06b1b47fd299003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=232508447&rft_id=info:pmid/18097141&rfr_iscdi=true |